Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Key Genes and Clinical Feature Analyses of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.

Genetic testing and molecular biomarkers - 1 Jun 2026

Niyaze Dilimureti, Shalitana Alai, Guo Jun, Guo Wenjia, Ainiwaer Ailixiati, Xu Keming, Sun Xiaohong, Yibulayin Waresijiang

Abstract excerpt

BACKGROUND: Lung adenocarcinoma (LUAD) is a prevalent and aggressive form of lung cancer, characterized by late-stage diagnosis, high metastatic potential, and recurrence. Epidermal growth factor receptor (EGFR) mutations are commonly observed in LUAD. However, other key genes associated with EGFR mutations in LUAD remain to be clarified. Therefore, this study aims to identify key genes associated with EGFR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to Nomograms

Share to Prognosis

Source

Identifiers

PMID: 42163810
DOI: 10.1177/19450265261440400

Genes

EGFR
AHSG
CD4
F2
TTN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Key Genes and Clinical Feature Analyses of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.PMID 42163810Read ↗

Development of a Coagulation-Related Genes Model for Prognostication, Immune Response, and Treatment Prediction in Lung AdenocarcinomaSemantic proximity Read ↗

The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformaticsSemantic proximity Read ↗

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.Semantic proximity Read ↗

Identification of lung adenocarcinoma subtypes and a prognostic signature based on activity changes of the hallmark and immunologic gene setsSemantic proximity Read ↗

Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung AdenocarcinomaSemantic proximity Read ↗

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genesSemantic proximity Read ↗

Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.Semantic proximity Read ↗

An RNA Modification–Associated Gene-Based Prognostic Model and Its Relevance to the Immune Microenvironment and Therapeutic Response in Lung AdenocarcinomaSemantic proximity Read ↗

Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinomaSemantic proximity Read ↗

Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation.Semantic proximity Read ↗

Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironmentSemantic proximity Read ↗

Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.